ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Darolutamide NDA to treat non-metastatic castration-resistant prostate cancer
April 12, 2019A New Drug Application has been made to the US Food and Drug Administration for the drug darolutamide to treat non-metastatic prostate cancer… -
Bayer files prostate cancer drug darolutamide in Japan
March 07, 2019Bayer has filed its prostate cancer drug darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas. -
Bayer plans filings for prostate cancer drug darolutamide
December 20, 2018Bayer is planning regulatory filings of darolutamide in prostate cancer following phase III trial results showing it helped prevent the disease from spreading, in a niche where Pfizer and Johnson & Johnson have already gained a foothold.
Pharma Sources Insight January 2025
